汪广厚, 王晶, 齐伟, 陈扬, 孙立新. 吲哚美辛5-氟尿嘧啶甲酯的代谢物5-氟尿嘧啶在大鼠体内组织分布和排泄J. 药学学报, 2008, 43(1): 81-85.
引用本文: 汪广厚, 王晶, 齐伟, 陈扬, 孙立新. 吲哚美辛5-氟尿嘧啶甲酯的代谢物5-氟尿嘧啶在大鼠体内组织分布和排泄J. 药学学报, 2008, 43(1): 81-85.
WANG Guang-hou, WANG Jing, QI Wei, CHEN Yang, SUN Li-xin. Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in ratsJ. Acta Pharmaceutica Sinica, 2008, 43(1): 81-85.
Citation: WANG Guang-hou, WANG Jing, QI Wei, CHEN Yang, SUN Li-xin. Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in ratsJ. Acta Pharmaceutica Sinica, 2008, 43(1): 81-85.

吲哚美辛5-氟尿嘧啶甲酯的代谢物5-氟尿嘧啶在大鼠体内组织分布和排泄

Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in rats

  • 摘要: 采用高效液相色谱法对吲哚美辛5-氟尿嘧啶甲酯(indomethacin 5-fluorouracil-1-ylmethyl ester,IFM)的代谢物5-氟尿嘧啶在大鼠体内的分布和排泄进行研究。生物样品经液-液萃取后,以甲醇-水-36%乙酸(3∶96.9∶0.1,v/v)或甲醇-水-36%乙酸(10∶89.9∶0.1,v/v)为流动相,使用DiamonsilTM C18色谱柱进行分离,检测波长为260 nm。大鼠灌胃IFM 100 mg·kg-1后, 5-氟尿嘧啶在胃、 小肠、 肝组织中浓度较高,其他组织和血浆中较低。5-氟尿嘧啶从尿液(0~24 h)、粪便(0~48 h)中排泄量分别占给药总量的0.006 5%和0.063%。该方法准确、专属性强,适用于IFM代谢物5-氟尿嘧啶的临床前药代动力学研究。

     

    Abstract: To study the tissue distribution and excretion of indomethacin 5-fluorouracil-1-ylmethyl ester (IFM) metabolite 5-fluorouracil in rats, an accurate and specific high performance liquid chromatography method for quantifying IFM in rat plasma and tissues was developed. Biological samples were prepared by liquid-liquid extraction and separated on a DiamonsilTM C18 column (250 mm×4.6 mm ID, 5 μm). The mobile phase for tissue samples, plasma samples and feces samples were composed of methanol-water-36% acetic acid (3∶96.9∶0.1, v/v) and the mobile phase for urine samples was a mixture of methanol-water-36% acetic acid (10∶89.9∶0.1, v/v). The eluate was monitored by UV absorbance at 260 nm. After a single ig dose of 100 mg·kg-1 IFM in rats, 5-Fu was mainly distributed in stomach, small intestine, and liver. The concentrations of 5-fluorouracil in other tissues and plasma were low. The excretion of 5-Fu in urine and feces amounted to 0.006 5% and 0.063% of the dose, respectively. The method is shown to be accurate and specific, and suitable for preclinical pharmacokinetic studies of IFM.

     

/

返回文章
返回